Predictive analytics

Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.

Juan Lavista Ferres, CVP and chief data scientist at Microsoft's AI for Good Lab, and Meghana Kshirsagar, senior research scientist, discuss their research on protein symmetry.

Ran Balicer, chief innovation officer at Clalit Health Services, believes AI implementation is necessary to advance healthcare and recommends that organizations create guardrails to ensure safe, ethical AI deployment.

Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.

Priyanka Jain, CEO and cofounder of Evvy, discusses the women's health company's vaginal health test, which includes fertility insights by identifying specific markers in the vaginal microbiome that may be linked to fertility outcomes.

Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.

Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.

David Lareau, Medicomp Systems' CEO and president, says 8% to 10% of AI-captured information from complex encounters may be incorrect, but that the company's tool can flag these issues for clinicians to review.

Luke Hansen, chief medical officer at Arcadia, provides MobiHealthNews with highlights of the event for the company and its plans for 2025.

It has achieved high accuracy in predicting postoperative pain, considering blood volume change, heart rate, and blood pressure.